Within the scientific trial experience with Xyrem in narcolepsy/cataplexy sufferers at therapeutic doses, two patients described nervousness and a single claimed insomnia following abrupt discontinuation within the termination in the scientific trial; in the two people with stress, the frequency of cataplexy had greater markedly concurrently.Electr